Permanent combinations of breathable corticoids and slow-acting ß2 sympathomimetics for long-time therapy of asthma bronchiale;Feste Kombinationen inhalierbarer Kortikoide und langwirkender ß2-Sympathomimetika zur Langzeittherapie des Asthma bronchiale

Pneumologie

Volumn 53, Issue 4, 1999, Pages 210-212

  Buhl, R ^a   Kardos, P ^a   Magnussen, H ^a   Matthys, H ^a   Sauer, R ^a   Schauer, P ^a   Vogelmeier, C ^a   Wettengel, R ^a   Worth, H ^a   Menz, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DRUG DERIVATIVE; FLUTICASONE; SALBUTAMOL; SALMETEROL;

ASTHMA; DELAYED RELEASE FORMULATION; DOSE RESPONSE; DRUG COMBINATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HUMANS;

EID: 0033113696     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Barnes NC, Corris P, Elliott MW, Fleetham JA, Foley NM, Higgins BG, Hoiby N, Lewis SA, Miller MR, Rogers DF, Sly PD, Strachan DP, Walker WS, Winter RJD: The British guidelines on asthma management. Thorax 1997; 52: SI -S21
2. Barnes PJ: Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol 1998; 102: 531 - 538
3. Barnes PJ, Woolcock AJ: Difficult asthma. Eur Respir J 1998; 12: 1209-1218
4. Bateman ED, Britton M, Carrillo T, Almeida J, Wixon C: Salmeterol/fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma. Clin Drug Invest 1998; 16: 193 201
5. Biais L, Suissa S, Boivin J-F, Ernst P: First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax 1998; 53: 1025 - 1029
6. Bosley CM, Parry OT, Cochrane CM: Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? Eur Respir J1994; 7: 504-509
7. Britton MG, Carrillo T, Almeida J, Wixon C: Combined serevent and fluticasone propionate (50/100 ug strength) bd via one diskus (accuhaler) inhaler compared with salmeterol 50 (ig and fluticasone propionate 100 ug bd via two seperate diskus inhalers. Am J Respir Crit Care Med 1998; 157: A415
8. Cochrane CM: Compliance and outcomes in patients with asthma. Drugs 1996; 52 suppl. 6: 12 - 19
9. Cramer JA, Mattson RH, Prevey MC, Scheyer RD, Ovellette VL; How often is medication taken as prescribed? JAMA 1989; 261:3273-3277
10. Dompeling E, Grunsven Van PM, Schayck Van CP, Folgering H, Molema J, Weel Van C: Treatment with inhaled steroids in asthma and chronic bronchitis: long term compliance and inhaler technique. Fam Pract 1992; 9:161 -166
11. Edwards T, Gross G, Mitchell D, Chervinsky P, Woodring A, Baitinger L, Prillaman B, House K, Shah T: The salmeterol xinafoate/fluticasone propionate dry powder combination product via diskus inhaler improves asthma control compared to salmeterol xinafoate or fluticasone dry powder alone. Am J Respir Crit Care Med 1998; 157: A414
12. Fülgraff G, Palm D: Pharmakotherapie - klinische Pharmakologie. Stuttgart: Gustav Fischer Verlag; 1995
13. Gerrits CMJM, Herings RMC, Lammers J-WJ, Leufkens HGM: Too low usage of inhaled steroids among patients with long-acting ß2-agonists. Eur Respir J 1998; 12: 156s - 157s
14. Greening AP, Ind PW, Northfield M, Shaw G: Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219 224
15. Gross G, Woodring A, Prillaman B, House K, Shah T: Efficacy and safety of the salmeterol/fluticasone propionate ( 50/100 ug) dry powder combination inhaler in patients with asthma. Eur Respir J 1998; 12: 156s
16. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, Sovijärvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA: Comparison of a ß2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325: 388-392
17. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos 0, Sovijärvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA: Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700 - 705
18. Horn CR, Essex E, Hill P, Cochrane CM: Does urinary salbutamol reflect compliance with the aerosol regimen in patients with asthma? Respir Med 1989; 83:15 -18
19. Jatakanon A, Lim S, Chung KF, Barnes PJ: An inhaled steroid improves markers of airway inflammation in patients with mild asthma. Eur Respir J. 1998; 12: 1084-1088
20. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE: Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990; 142: 832 - 836
21. Kelloway JS, Wyatt RA, Adlis SA: Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Int Med 1994; 154:1349 - 1352
22. Kerstjens HAM, Brans PLP, Hughes MD, Robinson NJ, Postma DS, Sluiter HJ, Bleecker ER, Dekhuijzen PNR, De Jong PM, Mengeleers HJJ, Overbeek SE, Schoonbrood DFME and Dutch chronic nonspecific lung disease study group: A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992; 327: 1413 1419
23. National Heart, Lung and Blood Institute: Guidelines for the diagnosis and management of asthma. Report; 1997
24. Pauwels RA, Löfdahl C, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A: Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405-1411
25. Postolache P, Petrescu 0: Evaluation of therapeutical effects of salmeterol and fluticasone propionate in asthma using quality of life questionnaire of Juniper and Guyait. Eur Respir J 1998; 12: 155s
26. Reese PR, Mahajan P, Woodring A: Salmeterol/fluticasone propionate combination product improves quality of life in asthma patients. Eur Respir J1998; 12: 35s
27. Schlosser NJJ, Steinmetz K-0, Aubier M, Gomez E, Wixon C: Evaluation of longterm safety of salmeterol/fluticasone propionate (50/500 ng) combination inhaler in patients with reversible airways obstruction. Eur Respir J 1998; 12: 35s
28. Berg van den NJ, Ossip M, Hederos CA, Anttila H, Davies P: Combined salmeterol xinofoate and fluticasone propionate (50/ 100 (ig strength) bd via one diskus (Accuhaler) inhaler compared with salmeterol xinafoate 50 (ig and fluticasone propionate 100(ig bd via two separate diskus inhalers. Eur Respir J 1998; 12: 157s
29. Wettengel R, Berdel D, Hofmann D, Krause J, Kroegel C, Kroidl RF, Leupold W, Lindemann H, Magnussen H, Meister R, Morr H, Nolte D, Rabe KF, Reinhardt D, Sauer R, Schultze-Werninghaus G, Ukena D, Worth H: Empfehlungen zur Asthmatherapie bei Kindern und Erwachsenen. Pneumologie 1998; 52: 591 -601
30. Wiewrodt R, Dauletbaev N, Buhl R: Wirksamkeit und Verträglichkeit einer Kombination von Fluticason und Salmeterol bei Patienten mit obstruktiver Atemwegserkrankung. Pneumologie 1998; 51: 14-20
31. Woolcock A, Lundback B, Ringdal N, Jacques LA: Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481 -1488